Protein Analysis
Ultra-sensitive NanoLC-MS technique to identify proteins from the gel, solution or complex mixture, etc… Our turn around time is five business days.More
Ultra-sensitive NanoLC-MS technique to identify proteins from the gel, solution or complex mixture, etc… Our turn around time is five business days.More
Protein Mutation & Sequence Variant Analysis
Analyzing protein mutations to obtain complete sequence of a mutated protein…More
Analyzing protein mutations to obtain complete sequence of a mutated protein…More
Antibody De Novo Sequencing
ProtTech offer the service for the complete de novo sequencing of mAb and other proteins. The service is based on the proprietary protein sequencing technology that we ...More
ProtTech offer the service for the complete de novo sequencing of mAb and other proteins. The service is based on the proprietary protein sequencing technology that we ...More
Recombinant Antibody Expression
Based on the need of a customer, the service is started with an antibody sequence provided by customers of expressed antibody or antibody expression cell lines delivery to the customer...More
Based on the need of a customer, the service is started with an antibody sequence provided by customers of expressed antibody or antibody expression cell lines delivery to the customer...More
Therapeutic mAb & Protein Characterization
complete analysis of protein primary structure, N- and C-terminals, disulfide bond linkage, etc…More
complete analysis of protein primary structure, N- and C-terminals, disulfide bond linkage, etc…More
Developing Antibodies for Difficult Targets
We have developed the proprietary technologies for antigen design, immunization and screening high affinity antibodies against the extracellular domains of those difficult drug targets...More
We have developed the proprietary technologies for antigen design, immunization and screening high affinity antibodies against the extracellular domains of those difficult drug targets...More
Neutralized Antibody Drug Discovery
We have developed the proprietary technologies for antigen design, immunization and screening high affinity antibodies against the extracellular domains of those difficult drug targets...More
We have developed the proprietary technologies for antigen design, immunization and screening high affinity antibodies against the extracellular domains of those difficult drug targets...More
Fusion Platform for Therapeutic Proteins & Nanobodies
ProtTech has developed a novel AT-fusion platform (patent pending) to increase the in vivo half life of cell signaling proteins and nanobodies for therapeutic applications.More
ProtTech has developed a novel AT-fusion platform (patent pending) to increase the in vivo half life of cell signaling proteins and nanobodies for therapeutic applications.More